Cargando…
Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide
Temozolomide (TMZ, 3,4-dihydro-3-methyl-4-oxoimidazo [5,1-d]-as-tetrazine-8-carboxamide) is a new alkylating agent with promising antitumour efficacy for malignant gliomas. The resistance of tumour cells to TMZ is primarily associated with levels of the alkylguanine alkyltransferase (AGT). O(6)-benz...
Autores principales: | Kanzawa, T, Germano, I M, Kondo, Y, Ito, H, Kyo, S, Kondo, S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394478/ https://www.ncbi.nlm.nih.gov/pubmed/12942127 http://dx.doi.org/10.1038/sj.bjc.6601193 |
Ejemplares similares
-
Inhibition of platelet-derived growth factor signalling induces autophagy in malignant glioma cells
por: Takeuchi, H, et al.
Publicado: (2004) -
Antitumour effect of cyclin-dependent kinase inhibitors (p16(INK4A), p18(INK4C), p19(INK4D), p21(WAF1/CIP1) and p27(KIP1)) on malignant glioma cells
por: Komata, T, et al.
Publicado: (2003) -
Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids
por: Günther, W, et al.
Publicado: (2003) -
Correlation between genetic alterations and growth of human malignant glioma xenografted in nude mice
por: Leuraud, P, et al.
Publicado: (2003) -
Current and Future Gene Therapy for Malignant Gliomas
por: Kanzawa, Takao, et al.
Publicado: (2003)